【摘 要】
：
Oxime and oxime ethers have attracted much interest due to their chemical properties and biological activity.Steroidal oximes and their derivatives are known to exhibit anti-inflammatory, anticancer a
【机 构】
：
State Key Laboratory of Quality Research in Chinese Medicine, and Macau Institute for Applied Resear
论文部分内容阅读
Oxime and oxime ethers have attracted much interest due to their chemical properties and biological activity.Steroidal oximes and their derivatives are known to exhibit anti-inflammatory, anticancer and other pharmacological activity.
其他文献
Polypeptide drugs cause increasing attention due to their application in clinical treatment.On the one hand, many linear peptides have good stability and biological activity in vitro, they degradate r
The PDBbind database is created to provide a comprehensive collection of the binding data for the biomolecular complexes deposited in the Protein Data Bank (PDB).It thus provides a link between energe
A series of novel halogenated 1-benzyl-1-ethyl-3-phenylthiourea derivatives were synthesized by reacting isothiocyanatobenzene and some halogenated N-benzylethanamine.All these compounds have been cha
G-Quadruplex, differing from other DNA structures like duplex structures, hairpin, triplex, and i-motif structures, is formed by human DNA sequences that consist of tandem guanine (G) nucleotides fold
血脑屏障(BBB)主要是由脑毛细血管内皮细胞及其之间丰富的紧密连接构成的血液屏障,在中枢神经系统内环境稳定的维持中起着重要的作用.然而,在神经系统疾病中,BBB的存在也导致很多诊断和治疗药物无法进入脑部病灶,成为神经系统疾病的一大难题.
MnSOD is thought to be essential in a series of CNS disorders including Alzheimers disease, Parkinsons disease, stroke and etc.Various therapeutic strategies have been developed, especially synthesize
我们课题组致力于siRNA的成药性研究.我们的研究目标:一是合成修饰性siRNA从而提高血清稳定性,在一定程度上降低脱靶效应;二是对于RNA干扰通路中关键蛋白的机制研究.已经有文献证明,人体RNA解旋酶(RHA)能够将双链siRNA负载到RISC复合物上.
RNAi(RNA干扰)是一种有效的基因调控机制,它是通过依赖基因序列的方式来抑制靶基因的表达[1].基因治疗的成功在很大程度上取决于传递载体,低传递效率以及脱靶效应是目前siRNA应用于临床治疗的主要障碍,最近的研究发现,纳米颗粒可以有效地包裹RNA,并高效地将RNA传递到肿瘤细胞和其他含有网状内皮烯酮的组织中[2].
RNA干扰(RNA interference),是一种能够有效抑制基因表达的靶向性转录后基因沉默机制.通过这种机制,可以实现对相关疾病的治疗1.但是截止2013年上旬,依然没有一个药物能够通过FDA的批准进入药物市场,其主要原因是缺乏有效的siRNA的给药体系.
Phosphylated adducts can be used to monitor organophosphates (OPs) poisoning[1].In this paper, we describe recent advances in tyrosine, serine and lysine which are employed as motifs for OPs binding t